Precigen (PGEN) Profit After Tax (2012 - 2026)
Precigen (PGEN) reported Profit After Tax of -$7.9 million for Q1 2026, up 85.36% year-over-year from -$4.3 million in Q1 2025, and up 66.26% quarter-over-quarter from -$23.5 million in Q4 2025.
Precigen (PGEN) Profit After Tax (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Profit After Tax data on file, last reported at -$7.9 million in Q1 2026.
- Profit After Tax for Q1 2026 came in at -$7.9 million, up 85.36% year-over-year; the trailing twelve-month figure through Mar 2026 was -$204.4 million (down 30.49% YoY), and the FY2025 annual result was -$250.6 million, down 98.55% from the prior year.
- Profit After Tax advanced to -$7.9 million in Q1 2026 per PGEN's latest filing, from -$23.5 million in the prior quarter.
- Over five years, Profit After Tax peaked at $87.4 million in Q3 2022 and troughed at -$146.3 million in Q3 2025.
- A 5-year average of -$26.6 million and a median of -$22.7 million in 2023 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2022 and 2025: Profit After Tax surged 393.57% in 2022, then plunged 510.33% in 2025.
- A 5-year view of Profit After Tax shows it stood at -$22.2 million in 2022, then plunged by 49.06% to -$33.1 million in 2023, then surged by 40.32% to -$19.7 million in 2024, then slipped by 19.14% to -$23.5 million in 2025, then soared by 66.26% to -$7.9 million in 2026.
- Business Quant data shows PGEN's Profit After Tax at -$7.9 million in Q1 2026, -$23.5 million in Q4 2025, and -$146.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -56.74 Mn |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | -7.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.93 Mn |
| Dec 31, 2025 | -23.50 Mn |
| Sep 30, 2025 | -146.34 Mn |
| Jun 30, 2025 | -26.64 Mn |
| Mar 31, 2025 | -54.15 Mn |
| Dec 31, 2024 | -19.73 Mn |
| Sep 30, 2024 | -23.98 Mn |
| Jun 30, 2024 | -58.79 Mn |
| Mar 31, 2024 | -23.74 Mn |
| Dec 31, 2023 | -33.06 Mn |
| Sep 30, 2023 | -19.80 Mn |
| Jun 30, 2023 | -20.32 Mn |
| Mar 31, 2023 | -22.73 Mn |
| Dec 31, 2022 | -22.18 Mn |
| Sep 30, 2022 | 87.38 Mn |
| Jun 30, 2022 | -17.64 Mn |
| Mar 31, 2022 | -19.25 Mn |
| Dec 31, 2021 | -25.03 Mn |
| Sep 30, 2021 | -29.76 Mn |
| Jun 30, 2021 | -20.05 Mn |